EI
LGND icon

Ethic Inc’s Ligand Pharmaceuticals LGND Stock Holding History

Ethic Inc’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Buy
+933
New +$220K ﹤0.01% 1138

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Ethic Inc's LGND Position: Q2 2026 in Review

Ethic Inc opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 933 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #1138 among its holdings.

116 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Ethic Inc held 933 shares of Ligand Pharmaceuticals worth $295K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Ethic Inc position in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1138 holding.
  • 116 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.